Dapagliflozin reduces risks of kidney failure, cardiovascular or renal death.
| Autor: | Houck, Kristine |
|---|---|
| Zdroj: | Nephrology News & Issues; Nov2020, Vol. 34 Issue 11, p22-23, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|
| Autor: | Houck, Kristine |
|---|---|
| Zdroj: | Nephrology News & Issues; Nov2020, Vol. 34 Issue 11, p22-23, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|